| Primary |
| Constipation |
27.5% |
| Product Used For Unknown Indication |
15.6% |
| Colonoscopy |
8.3% |
| Dry Eye |
8.3% |
| Bowel Preparation |
5.5% |
| Anxiety |
3.7% |
| Diabetes Mellitus |
3.7% |
| Panic Attack |
3.7% |
| Surgery |
3.7% |
| Irritable Bowel Syndrome |
2.8% |
| Musculoskeletal Pain |
2.8% |
| Anaemia Vitamin B12 Deficiency |
1.8% |
| Back Pain |
1.8% |
| Depression |
1.8% |
| Fluid Retention |
1.8% |
| Hypertension |
1.8% |
| Muscle Relaxant Therapy |
1.8% |
| Routine Health Maintenance |
1.8% |
| Accidental Exposure |
0.9% |
| Anaemia |
0.9% |
|
| Pharmaceutical Product Complaint |
18.6% |
| Throat Irritation |
11.6% |
| Urticaria |
11.6% |
| Vomiting |
9.3% |
| Pharyngeal Oedema |
7.0% |
| Anaphylactic Shock |
4.7% |
| Colitis Ischaemic |
4.7% |
| Underdose |
4.7% |
| Abdominal Distension |
2.3% |
| Abdominal Pain |
2.3% |
| Abdominal Pain Upper |
2.3% |
| Abdominal Tenderness |
2.3% |
| Anaphylactic Reaction |
2.3% |
| Application Site Infection |
2.3% |
| Blood Glucose Decreased |
2.3% |
| Bowel Movement Irregularity |
2.3% |
| Circumoral Oedema |
2.3% |
| Convulsion |
2.3% |
| Diarrhoea |
2.3% |
| Discomfort |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
50.4% |
| Drug Use For Unknown Indication |
13.9% |
| Hypertension |
5.0% |
| Constipation |
4.2% |
| Bowel Preparation |
3.9% |
| Colonoscopy |
2.7% |
| Malignant Lymphoid Neoplasm |
2.7% |
| Bipolar Disorder |
1.8% |
| Depression |
1.8% |
| Ill-defined Disorder |
1.8% |
| Laxative Supportive Care |
1.8% |
| Back Pain |
1.5% |
| Kawasaki's Disease |
1.5% |
| Asthma |
1.2% |
| Dry Eye |
1.2% |
| Epilepsy |
1.2% |
| Arrhythmia |
0.9% |
| Bone Pain |
0.9% |
| Convulsion |
0.9% |
| Pain |
0.9% |
|
| Small Intestinal Obstruction |
9.5% |
| Thrombocytopenia |
9.5% |
| Colitis Ischaemic |
7.1% |
| Meningitis Aseptic |
7.1% |
| Pulmonary Alveolar Haemorrhage |
7.1% |
| Pyrexia |
7.1% |
| Drug Interaction |
4.8% |
| Hyponatraemia |
4.8% |
| Lichen Planus |
4.8% |
| Mallory-weiss Syndrome |
4.8% |
| Metabolic Acidosis |
4.8% |
| Pancytopenia |
4.8% |
| Rhabdomyolysis |
4.8% |
| Weight Decreased |
4.8% |
| Altered State Of Consciousness |
2.4% |
| Anaphylactic Shock |
2.4% |
| Atrial Fibrillation |
2.4% |
| Blindness |
2.4% |
| Blood Creatine Phosphokinase Increased |
2.4% |
| Blood Glucose Decreased |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.1% |
| Drug Use For Unknown Indication |
8.9% |
| Pain |
8.5% |
| Constipation |
7.2% |
| Prophylaxis |
4.0% |
| Hypertension |
3.4% |
| Nausea |
2.9% |
| Multiple Myeloma |
2.9% |
| Depression |
2.2% |
| Insomnia |
1.7% |
| Acute Lymphocytic Leukaemia |
1.5% |
| Back Pain |
1.4% |
| Adverse Event |
1.4% |
| Osteoporosis |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Anxiety |
1.2% |
| Diffuse Large B-cell Lymphoma |
1.1% |
| Atrial Fibrillation |
1.1% |
| Multiple Sclerosis |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
|
| Pneumonia |
8.9% |
| Vomiting |
8.9% |
| Pain |
8.7% |
| Death |
6.6% |
| Weight Decreased |
5.5% |
| Pulmonary Embolism |
5.3% |
| Urinary Incontinence |
5.0% |
| Electrocardiogram Qt Prolonged |
4.7% |
| Renal Failure Acute |
4.7% |
| Sepsis |
4.5% |
| Weight Increased |
4.5% |
| Febrile Neutropenia |
3.9% |
| Neutropenia |
3.9% |
| Wheezing |
3.9% |
| Nausea |
3.7% |
| Pyrexia |
3.7% |
| Thrombocytopenia |
3.7% |
| Lung Disorder |
3.4% |
| General Physical Health Deterioration |
3.2% |
| Somnolence |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Delirium |
12.5% |
| Bone Pain |
8.3% |
| Hormone Therapy |
8.3% |
| Neoplasm Malignant |
8.3% |
| Arthralgia |
4.2% |
| Pain In Extremity |
4.2% |
| Sedation |
4.2% |
|
|
